EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Derivation of a Multivariable Psoriatic Arthritis Risk Estimation Tool ( PRESTO ): A Step Towards Prevention

Lihi Eder iD, Ker-Ai Lee, Vinod Chandran iD, Jessica Widdifield iD, Aaron M Drucker, Christopher Ritchlin iD, Cheryl F Rosen, Richard J Cook, Dafna D Gladman iD

Arthritis & Rheumatology · 2025

DOI: 10.1002/art.42661 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, 2025. Verfasst von Lihi Eder und 8 weiteren Autor:innen. Beteiligte Einrichtung: Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada, and Department of Medicine, University of Toronto, Toronto, O…. Hauptthemen laut MEDLINE: Arthritis, Psoriatic, Psoriasis. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: New Investigator Grant from the Physician Services Incorporated (PSI) Foundation, Canada Research Chair in Inflammatory Rheumatic Diseases (Tier 2), Pfizer Chair Research Award, Rheumatology, University of Toronto.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

A simple, scalable tool that identifies psoriasis patients at high risk for developing psoriatic arthritis (PsA) could improve early diagnosis. We aimed to develop a risk prediction model for the development of PsA and to assess its performance among patients with psoriasis.

Methods

We analyzed data from a prospective cohort of psoriasis patients without PsA at enrollment. Participants were assessed annually by a rheumatologist for the development of PsA. Information about their demographics, psoriasis characteristics, comorbidities, medications, and musculoskeletal symptoms was used to develop prediction models for PsA. Penalized binary regression models were used for variable selection while adjusting for psoriasis duration. Risks of developing PsA over 1‐ and 5‐year time periods were estimated. Model performance was assessed by the area under the curve (AUC) and calibration plots.

Results

Among 635 psoriasis patients, 51 and 71 developed PsA during the 1‐year and 5‐year follow‐up periods, respectively. The risk of developing PsA within 1 year was associated with younger age, male sex, family history of psoriasis, back stiffness, nail pitting, joint stiffness, use of biologic medications, patient global health, and pain severity (AUC 72.3). The risk of developing PsA within 5 years was associated with morning stiffness, psoriatic nail lesion, psoriasis severity, fatigue, pain, and use of systemic nonbiologic medication or phototherapy (AUC 74.9). Calibration plots showed reasonable agreement between predicted and observed probabilities.

Conclusions

The development of PsA within clinically meaningful time frames can be predicted with reasonable accuracy for psoriasis patients using readily available clinical variables. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, PsoriaticPsoriasisHumansMaleFemaleMiddle AgedAdultRisk AssessmentProspective StudiesRisk FactorsAge FactorsSex FactorsAgedSeverity of Illness Index

Autor:innen und Institutionen

  • Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada, and Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada.
  • Department of Medicine, University of Toronto, and Schroder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital, Toronto, Ontario, Canada.
  • Sunnybrook Research Institute, Sunnybrook Hospital, and Institute for Clinical Evaluative Sciences (ICES), and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
  • Women's College Research Institute, Women's College Hospital, and Department of Medicine, University of Toronto, and ICES, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontar…
  • Division of Rheumatology, University of Rochester, Rochester, New York.

ORCID-Profile: Lihi Eder, Vinod Chandran, Jessica Widdifield, Christopher Ritchlin, Dafna D Gladman

Förderung

  • New Investigator Grant from the Physician Services Incorporated (PSI) Foundation
  • Canada Research Chair in Inflammatory Rheumatic Diseases (Tier 2)
  • Pfizer Chair Research Award, Rheumatology, University of Toronto
  • Krembil Foundation

Zitieren

APA

Eder, L., Lee, K. A., Chandran, V., Widdifield, J., Drucker, A. M., Ritchlin, C., Rosen, C. F., Cook, R. J., & Gladman, D. D. (2025). Derivation of a Multivariable Psoriatic Arthritis Risk Estimation Tool ( PRESTO ): A Step Towards Prevention. Arthritis & Rheumatology. https://doi.org/10.1002/art.42661

Vancouver

Eder L, Lee KA, Chandran V, Widdifield J, Drucker AM, Ritchlin C, et al. Derivation of a Multivariable Psoriatic Arthritis Risk Estimation Tool ( PRESTO ): A Step Towards Prevention. Arthritis & Rheumatology. 2025. doi:10.1002/art.42661

BibTeX
@article{Eder2025,
  author = {Eder, Lihi and Lee, Ker-Ai and Chandran, Vinod and Widdifield, Jessica and Drucker, Aaron M and Ritchlin, Christopher and Rosen, Cheryl F and Cook, Richard J and Gladman, Dafna D},
  title = {Derivation of a Multivariable Psoriatic Arthritis Risk Estimation Tool ( PRESTO ): A Step Towards Prevention},
  journal = {Arthritis & Rheumatology},
  year = {2025},
  doi = {10.1002/art.42661}
}
Kostenlos starten →